AmerisourceBergen Profit Margin 2006-2018 | ABC

Current and historical gross margin, operating margin and net profit margin for AmerisourceBergen (ABC) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. AmerisourceBergen net profit margin as of December 31, 2018 is 0.69%.
AmerisourceBergen Annual Profit Margins
AmerisourceBergen Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $15.293B $167.940B
AmerisourceBergen Corporation provides pharmaceutical services. It distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers. The Company also provides pharmacy services to certain specialty drug patients. AmerisourceBergen Corporation is based in Chesterbrook, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $61.317B 20.37
Align Technology (ALGN) United States $22.518B 57.33
McKesson (MCK) United States $21.887B 8.52
Laboratory Of America Holdings (LH) United States $14.330B 13.18
Cooper (COO) United States $13.885B 24.22
Cardinal Health (CAH) United States $13.709B 9.24
DENTSPLY SIRONA (XRAY) United States $11.127B 24.74
Henry Schein (HSIC) United States $9.192B 14.85
West Pharmaceutical Services (WST) United States $8.223B 39.69
Merit Medical Systems (MMSI) United States $3.170B 34.12
CONMED (CNMD) United States $2.242B 36.43
Patterson (PDCO) United States $2.031B 16.05
Atrion (ATRI) United States $1.612B 47.31
STAAR Surgical (STAA) United States $1.380B 115.59
Antares Pharma (ATRS) United States $0.437B 0.00
Invacare (IVC) United States $0.222B 0.00
Lifevantage (LFVN) United States $0.158B 21.27
Pro-Dex (PDEX) United States $0.063B 28.64
Endologix (ELGX) United States $0.060B 0.00
Biolase (BIOL) United States $0.049B 0.00
Retractable Technologies (RVP) United States $0.023B 0.00
Milestone Scientific (MLSS) United States $0.015B 0.00